You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myelofibrosis

Showing 51 - 75 of 670
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myeloproliferative Tumor, Essential Thrombocythemia, Primary Myelofibrosis, Prefibrotic Stage Trial (CALR allele burden

Recruiting
  • Myeloproliferative Neoplasm
  • +3 more
  • CALR allele burden quantification
  • Angers, France
    CHU Angers
Nov 2, 2022

Polycythemia Vera, Essential Thrombocythemia, and

Not yet recruiting
  • Myeloproliferative Neoplasm
  • Next-generation sequencing
  • (no location specified)
Jun 27, 2022

Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis

Recruiting
  • Myelofibrosis
  • Hematopoietic Stem Cell Transplant
  • Minneapolis, Minnesota
    Center for International Blood and Marrow Transplant Research
Mar 17, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 7, 2022

Myelofibrosis Trial in Worldwide (Ruxolitinib)

Completed
Has Results
  • Myelofibrosis
  • Winter Park, Florida
  • +17 more
Jan 10, 2022

Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis Trial in United States

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Scottsdale, Arizona
  • +8 more
Feb 10, 2022

Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Polycythemia Vera
  • Phoenix, Arizona
  • +4 more
Jun 20, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 10, 2023

Myelofibrosis, Polycythemia Vera, Thrombocythemia Trial in Worldwide (itacitinib)

Active, not recruiting
  • Myelofibrosis
  • +2 more
  • New Orleans, Louisiana
  • +20 more
Aug 25, 2022

Myelofibrosis Trial in Australia (KER-050 monotherapy, KER-050 in combination with ruxolitinib)

Recruiting
  • Myelofibrosis
  • KER-050 monotherapy
  • KER-050 in combination with ruxolitinib
  • Tweed Heads, New South Wales, Australia
  • +4 more
Mar 2, 2022

Myeloproliferative Tumor, MPN, Essential Thrombocythemia Trial in Orange (N-Acetylcysteine)

Active, not recruiting
  • Myeloproliferative Neoplasm
  • +4 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Jan 6, 2023

Primary Myelofibrosis (PMF), Post Polycythemia Myelofibrosis (PPV MF), Thrombocythemia Myelofibrosis (PET-MF) Trial

Available
  • Primary Myelofibrosis (PMF)
  • +2 more
  • (no location specified)
Jan 18, 2022

Myelofibroses Trial in Saint Louis (Pevonedistat, Ruxolitinib, Peripheral blood draw)

Terminated
  • Myelofibroses
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 16, 2021

Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)

Recruiting
  • Myelofibrosis
  • Jaktinib hydrochloride tablets
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 29, 2021

A Prospective, Two-arm, Non-interventional Study of JAKAVI® in

Active, not recruiting
  • Primary Myelofibrosis
  • +2 more
  • Jakavi
  • Aachen, Germany
    Novartis Investigative Site
Sep 6, 2021

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +4 more
  • Eltrombopag Olamine
  • Houston, Texas
    M D Anderson Cancer Center
Jan 4, 2022

MDS, Myeloproliferative Tumors, Myelofibrosis Trial (Jaktinib, azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • (no location specified)
Nov 29, 2021

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, radiation)

Recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 21, 2022

Myelofibrosis Trial in Worldwide (PXS-5505)

Recruiting
  • Myelofibrosis
  • Birmingham, Alabama
  • +19 more
Nov 28, 2022

Myelofibrosis Trial in Worldwide (PIM447, Ruxolitinib, LEE011)

Completed
  • Myelofibrosis
  • VIC, Melbourne, Australia
  • +8 more
Feb 7, 2022

Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies Trial in Rochester (Imetelstat)

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Rochester, Minnesota
    (unnamed)
Aug 24, 2021

Primary Myelofibrosis, Prefibrotic Stage, Myelofibrosis Trial in Hong Kong (Ropeginterferon alfa-2b)

Recruiting
  • Primary Myelofibrosis, Prefibrotic Stage
  • Myelofibrosis
  • Ropeginterferon alfa-2b
  • Hong Kong, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
Jul 25, 2021

Accelerated/Blast-phase Myeloproliferative Tumor, Chronic-phase Myelofibrosis, IDH2 Mutation Trial in Canada, United States

Recruiting
  • Accelerated/Blast-phase Myeloproliferative Neoplasm
  • +2 more
  • Scottsdale, Arizona
  • +10 more
May 9, 2022

Myelofibrosis (MF) Trial in Korea, Republic of, South Africa, United States (Mivebresib, Navitoclax, Ruxolitinib)

Active, not recruiting
  • Myelofibrosis (MF)
  • Stony Brook, New York
  • +6 more
Mar 23, 2022

Moderate and High Risk Myelofibrosis Trial in China (TQ05105 tablets, Hydroxycarbamide tablets)

Recruiting
  • Moderate and High Risk Myelofibrosis
  • TQ05105 tablets
  • Hydroxycarbamide tablets
  • Beijing, Beijing, China
  • +3 more
Nov 23, 2021